Lundbeckfonden Ventures

What Lundbeckfonden Ventures does

Lundbeckfonden (The Lundbeck Foundation) is a Danish enterprise foundation (erhvervsfond) headquartered in Copenhagen, Denmark, with a primary mission of advancing neuroscience and brain research. Founded as the commercial foundation owning H. Lundbeck, it has expanded to a diversified portfolio encompassing strategic ownerships of Danish healthcare companies, direct biotech venture investments, and a substantial philanthropic grant program. The foundation distributes over DKK 500 million annually to Danish-based healthcare science research, with a stated 2030 target of EUR 134 million in average annual grants and a sharpened focus on the brain. The organization operates through three main arms: strategic ownerships of wholly-owned Danish healthcare companies (H. Lundbeck, ALK, Falck, Ferrosan Medical Devices, Ellab, WS Audiology), Lundbeckfonden BioCapital (direct biotech investments in Denmark and internationally supporting commercialization of breakthrough science), and Lundbeckfonden Invest (financial and alternative investments across forests, property, and diversified asset classes).

The foundation's core products span grant programs (LF Fellows, LF Professorships, LF Postdocs, LF Ascending Investigators, LF Experiment, Pre-Graduate Scholarships, Visiting Professorships), award programs including The Brain Prize (the world's largest neuroscience prize at approximately EUR 1.3 million annually, established 2011), and the Neurotorium educational platform for public brain science communication. Strategic technology platforms supported include LCO Probe Technology (h-FTAA) for differentiating alpha-synuclein strains in Parkinson's disease research, and AI-Assisted Brain Atlas technology for human brain mapping. The foundation maintains long-standing research partnerships with iPSYCH (Initiative for Integrative Psychiatric Research, co-founded in 2012), Aarhus University, University of Cambridge, and University of Bristol, alongside partnerships with major neuroscience societies including FENS, EAN, ECNP, Japan Neuroscience Society, and Cajal Training.

Lundbeckfonden's business model is hybrid: philanthropic grant-making funded by endowment returns and subsidiary dividends, combined with commercial investment activities through BioCapital and strategic ownerships. The foundation's grant-making operates on an open-competition basis with peer review panels, while strategic ownerships maintain healthcare industry leadership in Denmark. Revenue is generated indirectly through ownership stakes in operating subsidiaries (with H. Lundbeck being a major pharmaceutical company focused on psychiatric and neurological disorders) and through financial investment returns. The foundation is governed by a Board of Directors led by CEO Lene Skole, with no parent company, and employs 11-50 people directly. The foundation's stated 2030 strategy emphasizes doubling fixed research grants, building clearer brain-focused strategic priorities, expanding long-term healthcare ownerships, and strengthening research-business collaboration.

Name

Lundbeckfonden Ventures

Legal name

Lundbeckfonden

Website

https://lundbeckfonden.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Lundbeckfonden (The Lundbeck Foundation) is a Danish enterprise foundation that funds neuroscience research through annual grants exceeding DKK 500 million, operates The Brain Prize and Neurotorium platforms, and manages strategic ownerships in Danish healthcare companies alongside biotech venture investments.

Ownership category

akta.pro rank

Product category

Life Sciences Venture Capital & Research Funding

NAICS

Grantmaking Foundations (813211), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Investment Advice (6282)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Neuroscience research funding
• Biotech venture capital
• Biomedical grant programs
• Enterprise foundation investments
• Healthcare ownership holdings

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Others

Distribution channels5 records

Marketing channels6 records

Core offering

The Lundbeck Foundation is a Danish enterprise foundation that funds biomedical and neuroscience research through grants, prizes, and fellowships, awarding over DKK 500 million annually. It also operates Lundbeckfonden BioCapital, making direct equity investments in biotech companies in Denmark and internationally, and maintains long-term strategic ownership of Danish healthcare companies including H. Lundbeck, ALK, Falck, Ferrosan Medical Devices, Ellab, and WS Audiology. Its flagship programs include The Brain Prize (the world's largest neuroscience prize at DKK 10 million annually) and Neurotorium, a free educational platform on brain science.

Product overview

Lundbeckfonden (The Lundbeck Foundation) is a Danish enterprise foundation focused on advancing brain research and neuroscience. The organization operates a portfolio of programs including: The Brain Prize (the world's largest neuroscience prize at €1.3M annually), Neurotorium (free educational platform about the brain), Lundbeckfonden BioCapital (direct biotech investments), and multiple grant programs including LF Fellows, LF Professorships, LF Postdocs, LF Ascending Investigators, LF Experiment, Pre-Graduate Scholarships, and Visiting Professorships. Additionally, the foundation operates strategic ownerships in Danish healthcare companies including H. Lundbeck, ALK, Falck, Ferrosan Medical Devices, Ellab, and WS Audiology.

Differentiator

Problem solved

Functional benefit

Products and services

• The Brain Prize The world's largest brain research prize, awarded annually by the Lundbeck Foundation. Each year, 10 million DKK (approximately EUR 1.3 million) is awarded to one or more brain researchers who have made ground-breaking contributions to neuroscience.
• Neurotorium Free educational platform about the brain, with material developed and reviewed by experts, aimed at increasing public awareness and understanding of brain science.
• Lundbeckfonden BioCapital Direct equity investments in biotech companies in Denmark and internationally, supporting commercialization of breakthrough science through active collaboration.
• LF Fellows Fellowship grants for researchers within health sciences, supporting the next generation of scientific talents.
• LF Professorships Professorship grants supporting established researchers in biomedical sciences.
• LF Postdocs Postdoctoral fellowship grants for early-career researchers in health sciences.
• LF Ascending Investigators Grants for ascending researchers who are establishing independent research groups.
• Young Investigator Prize Prize recognizing outstanding young researchers in neuroscience or biomedical sciences.
• LF Experiment High-risk, high-reward research grants for ambitious scientific experiments.
• Pre-Graduate Scholarships Scholarships for pre-graduate students in health sciences.
• Visiting Professorships Grants supporting international visiting professors in research collaboration.

Quantifiable outcome

• 11% of age at autism diagnosis variance explained by genetics
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

13 partnerships are on record, tiered major, core and supporting.

• BioInnovation Institute (BII)majorStrategic or Co-development Partner · 2 March 2026BII is a Novo Nordisk Foundation Initiative providing €1.3 million follow-on funding to Danish startups. Lundbeckfonden's connection is through shared ecosystem support for Danish biotech companies. BII received €25 million funding from Novo Nordisk Foundation and supports product development across HealthTech, AgriTech, ClimateTech, and DeepTech.
• iPSYCH (Initiative for Integrative Psychiatric Research)coreStrategic or Co-development PartnerLong-standing partnership supporting one of the world's largest studies of genetic and environmental causes of psychiatric disorders including autism, ADHD, schizophrenia, bipolar disorder, and depression. iPSYCH involves more than 150 researchers and is co-funded by Lundbeckfonden together with Aarhus University, Region Hovedstaden, Statens Serum Institut, and others.
• European Academy of Neurology (EAN)supportingStrategic or Co-development PartnerPartner organization supporting The Brain Prize and neuroscience research collaboration across Europe
• Canadian Association for Neuroscience (CAN-ACN)supportingStrategic or Co-development PartnerPartner organization supporting neuroscience research and The Brain Prize awareness in Canada
• European College of Neuropsychopharmacology (ECNP)supportingStrategic or Co-development PartnerEuropean partner organization for neuropsychopharmacology research collaboration
• Japan Neuroscience SocietysupportingStrategic or Co-development PartnerPartner organization supporting neuroscience collaboration between Europe and Japan
• Cajal TrainingsupportingStrategic or Co-development PartnerPartner organization providing neuroscience training programs and courses
• The Korean Society for Brain and Neural SciencessupportingStrategic or Co-development PartnerPartner organization for Korean neuroscience research community engagement
• Federation of European Neuroscience Societies (FENS)supportingStrategic or Co-development PartnerEuropean umbrella organization for neuroscience societies supporting research collaboration
• NeurotoriumcoreStrategic or Co-development PartnerFree educational material about the brain developed and reviewed by experts, making neuroscience accessible to the public
• Aarhus UniversitycoreStrategic or Co-development PartnerKey research partner hosting iPSYCH researchers including professors Anders Børglum and Jakob Grove, contributing genetic data on 130,000 Danes for psychiatric research
• University of CambridgecoreStrategic or Co-development PartnerLed the British-Danish autism genetics study published in Nature, partnering with Aarhus University researchers
• University of BristolsupportingStrategic or Co-development PartnerPartner university contributing to the British-Danish autism genetics research study

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Gatsby Charitable Foundation: A UK-based foundation that funds neuroscience research (Gatsby Computational Neuroscience Unit at UCL) and plant science. It is a direct peer in neuroscience philanthropy with a UK/global grant footprint.
• Wellcome Trust: The UK's largest charitable foundation, with a multi-billion-pound endowment funding biomedical research and neuroscience, plus a venture arm (Wellcome Leap). It is the closest direct analog to Lundbeckfonden's hybrid philanthropy + commercial investing model in health research.
• Allen Institute for Brain Science: A nonprofit medical research organization focused on brain science, generating large public datasets (e.g., Allen Brain Atlas). It is a direct peer in the brain-specific philanthropic research space, with a comparable 'open science' orientation.
• Howard Hughes Medical Institute: A large US biomedical research organization that funds investigator-driven science, supports its own research campuses, and runs major neuroscience initiatives. It is a direct peer in the model of deploying an investment-derived endowment to drive fundamental and disease-focused research.
• Simons Foundation: A US philanthropic foundation funding major neuroscience initiatives (Simons Foundation Autism Research Initiative, Simons Institute for the Theory of Computing). It is a direct peer in funding large-scale brain research and is similarly well-capitalized through founder-derived endowment.
• Kavli Foundation: A US foundation that funds basic research in neuroscience, astrophysics, and nanoscience through endowed Kavli Institutes at major universities. It is a direct peer as a global neuroscience research funder, though at a smaller scale than Lundbeckfonden.
• Novo Nordisk Foundation: Denmark's other major enterprise foundation, with a similar hybrid model of strategic ownership (Novo Nordisk, Novozymes), venture investing, and large-scale research grants. It is the most direct Danish peer and operates a similar 'perpetual foundation owning industry' model.

Regional players

• BioInnovation Institute (BII): A Novo Nordisk Foundation initiative providing follow-on funding to Danish startups in HealthTech, AgriTech, ClimateTech, and DeepTech. It is a regional ecosystem peer that co-funds Danish biotech alongside Lundbeckfonden BioCapital.

Broad incumbents

• Bill & Melinda Gates Foundation: A much larger philanthropic foundation with substantial health research funding. It is a broad incumbent peer given its scale and venture-style investments in global health, though it is far larger and not brain-focused.

Emerging players

• Chan Zuckerberg Initiative: A US philanthropic vehicle using endowment-style investing to fund biomedical research (including neuroscience via the CZ Biohub Network). It is a more recent entrant with a similar hybrid model, though with broader research scope.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/lundbeckfonden
• YouTubeyoutube.com/lundbeckfonden
• Facebookfacebook.com/Lundbeckfonden
• LinkedInlinkedin.com/company/1770253
• Instagraminstagram.com/lundbeckfonden

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments66 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lundbeckfonden Ventures